Summary
Fever in systemic lupus erythematosus (SLE) may be caused by exacerbation of the disease itself or by infection. We report on a patient with a long standing history of SLE that was complicated by fever and pancytopenia with no splenomegaly. SLE disease activity was suspected because of an elevated DNA-antibody titer. The early positive response to corticoid therapy may have masked the underlying infection. Visceral leishmaniasis was diagnosed by a repeated bone marrow biopsy and serological testing.
Similar content being viewed by others
References
Schur, P.H. Clinical features of systemic lupus erythematous In: Textbook of Rheumatology. 3rd ed. Eds: Kelley, W.N., Harris, Jr. E.D., Ruddy, S., Sledge, C.B. Saunders WB Comp, 1989, 1101–1129.
Dubois, E.L. The clinical picture of systemic lupus erythematosus. In: Dubois' Lupus Erythematosus 3rd ed. Eds: Wallace, D.J., Dubois, E.L. Philadelphia 1987 317–450.
Locksley, R.M., Plorde, J.J. Leishmaniasis. In: Harrison's Principles of Internal Medicine, 2nd ed. Eds: Braunwald, E., Isselbacher, K.J., Petersdorf, R.G., Wilson J.D., Martin J.B., Fauci, A.S. Mc Graw-Hill 1987, 785–787.
Martinez, L., de Letona, J., Masa Vazquez, C., Perez Maestu, R., 1st letter Senaldi, G., Cadeo, G., Carnevale, G., Di Perri, G., Carosi, G. 2nd letter: Visceral leishmaniasis as an opportunistic infection. Lancet, 1986, i, 1094.
Badaro, R., Jones, T.C., Carvalho, E.M., Sampaio, D., Reed, S.G., Barral, A., Teixera, R., Johnson, Jr. W.D. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986, 154, 1003–1011.
Fernandez-Guerrero, M., Aguado, J., Buzon, L., Barros, C., Motalban, C., Martin, T., Bouza, E. Visceral lesishmaniasis in immunocompromised hosts. Am J Med 1987, 83, 1098–1102.
Chulay, J.D., Bhatt, S.M., Muigai, R. et al. A comparison of three dosage regimens of sodium stibogluconate in the treatment of viscerall leishmaniasis in Kenya. J Infect Dis 1983, 148, 148–155.
Carvalho, E.M., Bacellar, O., Barral, A., Badaro, R., Johnson, Jr W.D. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. J Clin Invest 1989, 83, 860–864.
Wallis, P.J.W., Clark, C.J.M. Visceral leishmaniasis complicating systemic lupus erythematosus, case report. Ann Rheum Dis 1983, 42, 201–202.
Cohen, J., Pinching, A.J., Rees, A.J., Peters, D.K. Infection and Immunosuppression. Q J Med, 1982, 201, 1–15.
Neva, F.A. Immunotherapy for parasitic disease (editorial). N Engl J Med 1990, 322, 55–57.
Beeson, P.B. Pyrexia of unknown origin. In: Oxford Textbook of Medicine 2nd ed., Eds: Weatherall, D.J., Ledingham, J.G.G., Warrell, D.A., Oxford University 1987, 605–608.
Petersdorf, R.G., Root, R.K. Chills and Fever. In Harrison's Principles of Internal Medicine 11th ed. Eds: Braunwald, E., Isselbacher, K.J., Petersdorf, R.G., Wilson, J.D., Martin, J.B., Fauci, A.S. Mc Graw-Hill 1987, 52–56.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Braun, J., Sieper, J., Schulte, K.L. et al. Visceral Leishmaniasis mimicking a flare of systemic lupus erythematosus. Clin Rheumatol 10, 445–448 (1991). https://doi.org/10.1007/BF02206670
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02206670